CausalSentinel

Protein Dossier — GNLY (Granulysin)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Birth weight 0.019 0.00556 6.29e-04 Wald ratio 1 cis NA
Height 0.012 0.00452 0.00788 Wald ratio 1 cis NA
Diagnoses - main ICD10: K44 Diaphragmatic hernia 0.0721 0.0277 0.00921 Wald ratio 1 cis NA
Bipolar disorder -0.1 0.0388 0.00966 Wald ratio 1 cis NA
Diastolic blood pressure automated reading -0.00913 0.0038 0.0164 Wald ratio 1 cis NA
Vascular or heart problems diagnosed by doctor: Angina -0.0512 0.0219 0.0195 Wald ratio 1 cis NA
Diagnoses - main ICD10: K40 Inguinal hernia 0.0499 0.0216 0.0209 Wald ratio 1 cis NA
Caudate volume 16.1 7.52 0.0324 Wald ratio 1 cis NA
IgA nephropathy -0.284 0.135 0.035 Wald ratio 1 cis NA
Age at menopause -0.0517 0.0259 0.0455 Wald ratio 1 cis NA
Non-cancer illness code self-reported: kidney stone or ureter stone or bladder stone -0.0919 0.0461 0.0461 Wald ratio 1 cis NA
Primary sclerosing cholangitis 0.0875 0.044 0.0466 Wald ratio 1 cis NA
…and 86 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3195_50_2 Granulysin Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

58 association rows across 24 traits (56 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating GNLY levels 6e-2124 rs7603438 5 GCST90860460 no MR -> candidate analysis
GNLY/GZMA protein level ratio 1e-2062 rs751163 1 GCST90314949 no MR -> candidate analysis
Granulysin levels 5e-802 rs12151621 14 GCST90247802 no MR -> candidate analysis
Serum levels of protein GNLY 7e-260 rs12151742 4 GCST90088260 no MR -> candidate analysis
Blood protein levels 5e-214 rs7603438 3 GCST006585 no MR -> candidate analysis
Granulysin levels (GNLY.3195.50.2) 7e-189 rs12151621 2 GCST90241322 no MR -> candidate analysis
Granulysin (analyte X14102.6) levels 7e-188 rs12151742 1 GCST90422468 no MR -> candidate analysis
Granulysin (analyte X3195.50) levels 2e-165 rs12151742 1 GCST90425647 no MR -> candidate analysis
GNLY protein levels 8e-158 rs192642287 12 GCST90469372 no MR -> candidate analysis
Cerebrospinal fluid protein GNLY levels 2e-87 rs7603438 1 GCST90944771 no MR -> candidate analysis
Granulysin level in Chronic kidney disease with hypertension 2e-51 rs12151742 1 GCST90234189 no MR -> candidate analysis
Granulysin level in Chronic kidney disease with hypertension 1e-44 rs12151742 1 GCST90237265 no MR -> candidate analysis
…and 12 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 331 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
cataract 0.19 0.19 exploratory rare-variant signal MR: beta=-0.0658, p=0.146 (cis)
vertebral column disorder 0.167 common-variant locus no MR -> candidate analysis
brain aneurysm 0.167 common-variant locus no MR -> candidate analysis
alcohol drinking 0.087 common-variant locus no MR -> candidate analysis

Of the 4 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 1 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=4.5e-05, LOEUF=1.25 — LoF-tolerant
GWAS Catalog 98 unique SNPs / 187 rows
ClinVar 60 records; 1 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance